Skip to main content

Carotid Stenosis clinical trials at UCSF
1 in progress, 1 open to new patients

  • Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

    open to eligible people ages 35 years and up

    Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will randomize patients in a 1:1 ratio to carotid stenting with embolic protection versus no stenting. Medical management will be uniform for all randomized treatment groups and will be centrally directed.

    San Francisco, California and other locations